Max Robotics — Global Service Robot Directory + US Certification

About

Yasumichi Takeuchi is a urologic surgeon and researcher whose work centers on advancing the surgical and multimodal management of prostate cancer, with a particular focus on high-risk and very-high-risk disease. His major contributions include pioneering studies on chemohormonal therapy followed by robot-assisted radical prostatectomy (RARP), demonstrating improved biochemical recurrence outcomes in very-high-risk patients (9 citations). He has also been instrumental in validating standardized training systems for RARP, comparing perioperative and surgical outcomes between experienced and novice surgeons at low-volume institutes in Japan, an effort that has garnered 9 citations and speaks to his commitment to surgical education and quality assurance. Additionally, Takeuchi has explored the efficacy and safety of neoadjuvant LHRH antagonist combined with tegafur-uracil chemohormonal therapy for high-risk prostate cancer (5 citations). Beyond prostate cancer, he has contributed to the rare disease literature with a case report on solitary fibrous tumor of the prostate (10 citations), one of only approximately 25 reported cases. His work, accumulating over 30 citations, reflects a focused dedication to improving surgical outcomes and expanding treatment options for complex urologic malignancies.